Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 4.06 USD 0.25% Market Closed
Market Cap: 620.4m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Operating Margin
Mereo Biopharma Group PLC

-511.3%
Current
-234%
Average
-7.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-511.3%
=
Operating Profit
-51.1m
/
Revenue
10m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
UK
Mereo Biopharma Group PLC
NASDAQ:MREO
620.4m USD
-511%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
300.2B USD
28%
US
Amgen Inc
NASDAQ:AMGN
158.7B USD
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.8B USD
40%
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
137.3B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.3B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.1B EUR
-22%
Country UK
Market Cap 620.4m USD
Operating Margin
-511%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 300.2B USD
Operating Margin
28%
Country US
Market Cap 158.7B USD
Operating Margin
19%
Country US
Market Cap 126.8B USD
Operating Margin
40%
Country US
Market Cap 115B USD
Operating Margin
38%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 137.3B AUD
Operating Margin
26%
Country US
Market Cap 88.3B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 34.1B EUR
Operating Margin
-22%

Profitability Report

View the profitability report to see the full profitability analysis for Mereo Biopharma Group PLC.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-511.3%
=
Operating Profit
-51.1m
/
Revenue
10m
What is the Operating Margin of Mereo Biopharma Group PLC?

Based on Mereo Biopharma Group PLC's most recent financial statements, the company has Operating Margin of -511.3%.